NICE reverses on Takeda drug after discount; Sandoz hit with $38M verdict in pricing case;

@FiercePharma: Quirky Medicaid rules gave generics firms a loophole to hike prices on capsules, but not tablets, whistleblower says. Report | Follow @FiercePharma

> Takeda Pharmaceutical's proposed discount on its bone cancer drug Mepact persuaded the U.K.'s cost effectiveness watchdog to recommend it for use by the National Health Service. Piece

> European regulators should require proposed drugs to be tested against existing treatments rather than placebo to make sure new meds add value, report says. Item

> Mississippi won a $38 million judgment against Sandoz, the generics unit of Novartis ($NVS), in an average wholesale pricing case. Report

> Merck ($MRK) was sued by three former employees who claim the company failed to pay their wages semi-monthly as required by West Virginia law. Report

> Sagent Pharmaceuticals got the FDA nod for its Haloperidol injection, a version of the schizophrenia drug Haldol. Article

> American Airlines Cargo has expanded its cold-chain service for pharma clients moving time- and temperature-sensitive drugs. Story

> New Zealand has rolled out a new national drug formulary encompassing clinical and reimbursement information. More

Biotech News

@FierceBiotech: Biomarkers vs. pen-and-paper tests for Alzheimer's: which wins? Story | Follow @FierceBiotech

@JohnCFierce: After a shakeup, iPierian names Nancy Stagliano, co-founder of CytomX, as new CEO. | Follow @JohnCFierce

@RyanMFierce: Researchers use neural #stem cells (of iPS variety) to study impacts of potential bipolar-disorder treatments. Article | Follow @RyanMFierce

> Fierce 15 f-star lands $708M antibody pact with Merck Serono. Piece

> Plexxikon's Hirth offers a "small" solution to Big Pharma's R&D woes. Story

> Eisai strikes creative deal to finance Ph3 cancer drug studies. News

Medical Device News

> St. Jude gets CE Mark for migraine device. News

> GI Dynamics starts trading on ASX. Report

> Veracyte thyroid test could reduce unnecessary procedures. More

> Urologix signs deal to sell Prostiva RF therapy system for BPH. Item

Drug Delivery News

> Virus sent on seek-and-destroy mission against cancer. Article

> Needle-free delivery market to double in 5 years, analyst says. Story

> Probiotics researcher says he's found a better delivery polymer. Article

> BDSI moves forward with anti-opioid drug, delivery method. Report

> Molecular motor could--someday--power drug delivery device. Piece

> Making sure your nanoparticles are pure. More

And Finally... Rich philanthropists aim to speed drug development for their children's debilitating diseases. Report

Suggested Articles

Six pharmaceutical execs are set to head to Washington next week for pricing hearings at the House Committee on Oversight and Reform. 

After sifting through the data, one analyst figures the latest Opdivo-Keytruda showdown in kidney cancer might come down to commercial execution.

Biogen is giving former chief finance officer Jeff Capello a multimillion-dollar cash payment plus other severance benefits.